145 related articles for article (PubMed ID: 23867305)
1. A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole.
Alai MS; Lin WJ
Colloids Surf B Biointerfaces; 2013 Nov; 111():453-9. PubMed ID: 23867305
[TBL] [Abstract][Full Text] [Related]
2. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
3. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization.
Adibkia K; Javadzadeh Y; Dastmalchi S; Mohammadi G; Niri FK; Alaei-Beirami M
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):155-9. PubMed ID: 21130612
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100.
Jana U; Mohanty AK; Manna PK; Mohanta GP
Colloids Surf B Biointerfaces; 2014 Jan; 113():269-75. PubMed ID: 24140793
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
6. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z
Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298
[TBL] [Abstract][Full Text] [Related]
7. Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations.
Alai M; Lin WJ
Int J Nanomedicine; 2015; 10():4029-41. PubMed ID: 26124659
[TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
[TBL] [Abstract][Full Text] [Related]
9. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
11. Composite CD-MOF nanocrystals-containing microspheres for sustained drug delivery.
Li H; Lv N; Li X; Liu B; Feng J; Ren X; Guo T; Chen D; Fraser Stoddart J; Gref R; Zhang J
Nanoscale; 2017 Jun; 9(22):7454-7463. PubMed ID: 28530283
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.
Jones E; Ojewole E; Kalhapure R; Govender T
Drug Dev Ind Pharm; 2014 May; 40(5):669-79. PubMed ID: 24576267
[TBL] [Abstract][Full Text] [Related]
13. Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.
Payab S; Davaran S; Tanhaei A; Fayyazi B; Jahangiri A; Farzaneh A; Adibkia K
Artif Cells Nanomed Biotechnol; 2016; 44(1):362-9. PubMed ID: 25180944
[TBL] [Abstract][Full Text] [Related]
14. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
Misra R; Acharya S; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
[TBL] [Abstract][Full Text] [Related]
15. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
Li Y; Wong HL; Shuhendler AJ; Rauth AM; Wu XY
J Control Release; 2008 May; 128(1):60-70. PubMed ID: 18406489
[TBL] [Abstract][Full Text] [Related]
16. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
17. Optimization and evaluation of bioactive drug-loaded polymeric nanoparticles for drug delivery.
Rani R; Dilbaghi N; Dhingra D; Kumar S
Int J Biol Macromol; 2015; 78():173-9. PubMed ID: 25881957
[TBL] [Abstract][Full Text] [Related]
18. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
Gandhi A; Jana S; Sen KK
Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
[TBL] [Abstract][Full Text] [Related]
19. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
[TBL] [Abstract][Full Text] [Related]
20. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]